CSIMarket
 


Merck and Co Inc   (MRK)
Other Ticker:  
 
 

MRK's Revenue Growth by Quarter and Year

Merck And Co Inc 's Revenue results by quarter and year




MRK Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - 14,631.00 13,830.00 12,068.00
III Quarter September - 15,962.00 14,959.00 13,154.00
II Quarter June 16,112.00 15,035.00 14,593.00 11,402.00
I Quarter March 15,775.00 14,487.00 15,901.00 12,080.00
FY   31,887.00 60,115.00 59,283.00 48,704.00



MRK Revenue second quarter 2024 Y/Y Growth Comment
Merck and Co Inc achieved in the second quarter 2024, above Company average Revenue improvement of 7.16% year on year, to $ 16,112.00 millions.

Looking into second quarter 2024 results within Major Pharmaceutical Preparations industry 80 other companies have achieved higher Revenue growth. While Merck And Co Inc ' s Revenue increase of 7.16% ranks overall at the positon no. 1055 in the second quarter 2024.




MRK Revenue ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter December - 5.79 % 14.6 % -3.56 %
III Quarter September - 6.7 % 13.72 % 4.8 %
II Quarter June 7.16 % 3.03 % 27.99 % 4.87 %
I Quarter March 8.89 % -8.89 % 31.63 % 0.19 %
FY   - 1.4 % 21.72 % 1.48 %

Financial Statements
Merck And Co Inc 's second quarter 2024 Revenue $ 16,112.00 millions MRK's Income Statement
Merck And Co Inc 's second quarter 2023 Revenue $ 15,035.00 millions Quarterly MRK's Income Statement


MRK Revenue (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter December - -8.34 % -7.55 % -8.26 %
III Quarter September - 6.17 % 2.51 % 15.37 %
II Quarter June 2.14 % 3.78 % -8.23 % -5.61 %
I Quarter March 7.82 % 4.75 % 31.76 % -3.47 %
FY (Year on Year)   - 1.4 % 21.72 % 1.48 %




Revenue second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #81
Healthcare Sector #200
Overall #1055

Revenue Y/Y Growth Statistics
High Average Low
112.1 % 6.69 % -10.57 %
(March 31, 2010)   (June 30. 2013)
Revenue second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #81
Healthcare Sector #200
Overall #1055
Revenue Y/Y Growth Statistics
High Average Low
112.1 % 6.69 % -10.57 %
(March 31, 2010)   (June 30. 2013)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Merck And Co Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
66.84 % 1.71 % -10.73 %
(Dec. 30, 2009)  


MRK's II. Quarter Q/Q Revenue Comment
Merck and Co Inc achieved in the II. Quarter 2024 above company average sequential Revenue growth of 2.14%, to $ 16,112.00 millions, from $15,775.00 millions in the first quarter.

Within Major Pharmaceutical Preparations industry 146 other companies have achieved higher Revenue quarter on quarter growth. While Merck And Co Inc 's Revenue growth quarter on quarter, overall rank is 2030.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #147
Healthcare Sector #364
Overall #2030
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #147
Healthcare Sector #364
Overall #2030
Revenue Q/Q Growth Statistics
High Average Low
66.84 % 1.71 % -10.73 %
(Dec. 30, 2009)  


MRK's II. Quarter Q/Q Revenue Comment
Merck and Co Inc achieved in the II. Quarter 2024 above company average sequential Revenue growth of 2.14%, to $ 16,112.00 millions, from $15,775.00 millions in the first quarter.

Within Major Pharmaceutical Preparations industry 146 other companies have achieved higher Revenue quarter on quarter growth. While Merck And Co Inc 's Revenue growth quarter on quarter, overall rank is 2030.


Merck And Co Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2024)
12 Months Ending
(Mar 31 2024)
12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
Cumulative Revenue 12 Months Ending $ 62,480.00 $ 61,403.00 $ 60,115.00 $ 59,314.00 $ 58,311.00
Y / Y Revenue Growth (TTM) 7.15 % 6.11 % 1.4 % 3.12 % 4.66 %
Year on Year Revenue Growth Overall Ranking # 477 # 908 # 268 # 321 # 2021
Seqeuential Revenue Change (TTM) 1.75 % 2.14 % 1.35 % 1.72 % 0.76 %
Seq. Revenue Growth (TTM) Overall Ranking # 597 # 1824 # 761 # 803 # 2642


Cumulative Revenue growth Comment
Although Merck And Co Inc 's Annual Revenue growth year on year were below company's average 7.29% , Revenue announced in the Jun 30 2024 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 7.15% year on year, from 6.11% in Mar 31 2024.

In the Healthcare sector 63 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 477, from total ranking in previous quarter at 908.

Revenue TTM Q/Q Growth Statistics
High Average Low
88.24 %
7.29 %
-7.58 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 24
Healthcare Sector # 64
Overall # 477

Revenue TTM Y/Y Growth Statistics
High Average Low
88.24 %
7.29 %
-7.58 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 24
Sector # 76
S&P 500 # 597
Cumulative Revenue growth Comment
Although Merck And Co Inc 's Annual Revenue growth year on year were below company's average 7.29% , Revenue announced in the Jun 30 2024 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 7.15% year on year, from 6.11% in Mar 31 2024.

In the Healthcare sector 63 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 477, from total ranking in previous quarter at 908.

Revenue TTM Q/Q Growth Statistics
High Average Low
88.24 %
7.29 %
-7.58 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 24
Healthcare Sector # 64
Overall # 477

Revenue TTM Y/Y Growth Statistics
High Average Low
88.24 %
7.29 %
-7.58 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 24
Sector # 76
S&P 500 # 597




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
MRK's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for MRK's Competitors
Revenue Growth for Merck And Co Inc 's Suppliers
Revenue Growth for MRK's Customers

You may also want to know
MRK's Annual Growth Rates MRK's Profitability Ratios MRK's Asset Turnover Ratio MRK's Dividend Growth
MRK's Roe MRK's Valuation Ratios MRK's Financial Strength Ratios MRK's Dividend Payout Ratio
MRK's Roa MRK's Inventory Turnover Ratio MRK's Growth Rates MRK's Dividend Comparisons



Companies with similar Revenue growth for the quarter ending Jun 30 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2024
Revance Therapeutics Inc 12.48%$ 12.480 millions
Adm Tronics Unlimited Inc 12.48%$ 12.476 millions
Ensign Group Inc12.48%$ 12.475 millions
Regeneron Pharmaceuticals Inc 12.32%$ 12.318 millions
Elanco Animal Health Inc12.02%$ 12.015 millions
Heron Therapeutics Inc 11.79%$ 11.788 millions
Sonida Senior Living Inc 11.70%$ 11.699 millions
Regenxbio Inc 11.60%$ 11.603 millions
Xenetic Biosciences Inc 11.58%$ 11.582 millions
Silk Road Medical Inc 11.51%$ 11.507 millions
Atrion Corporation11.26%$ 11.257 millions
Iradimed Corporation11.15%$ 11.150 millions
Organogenesis Holdings Inc 11.01%$ 11.011 millions
Zynex inc 10.97%$ 10.969 millions
Bausch Health Companies Inc 10.89%$ 10.891 millions
Lemaitre Vascular Inc 10.75%$ 10.746 millions
Coherus Biosciences inc 10.67%$ 10.667 millions
Ufp Technologies Inc 10.42%$ 10.423 millions
U S Physical Therapy Inc10.37%$ 10.367 millions
Hca Healthcare Inc 10.28%$ 10.283 millions
Universal Health Services Inc 10.13%$ 10.131 millions
Addus Homecare Corporation10.07%$ 10.069 millions
Y mabs Therapeutics inc 9.86%$ 9.865 millions
Biotricity Inc 9.77%$ 9.773 millions
Integra Lifesciences Holdings Corp9.68%$ 9.680 millions
Omniab Inc 9.62%$ 9.617 millions
Encompass Health Corporation9.61%$ 9.612 millions
Vanda Pharmaceuticals Inc 9.59%$ 9.593 millions
Incyte Corporation9.34%$ 9.339 millions
Resmed Inc 9.33%$ 9.329 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com